Folate Plays a Role in Neurotransmitter Production1

L-methylfolate helps enhance production of 3 key neurotransmitters. This stimulated production is important because many antidepressants require a sufficient amount of neurotransmitters associated with mood.

Copyright ©2008 Stephen M. Stahl. Reproduced with the permission of Cambridge University Press.5

Folate, when metabolized into active L-methylfolate, crosses the blood-brain barrier and is thought to help stimulate production of essential neurotransmitters.1-6

L-methylfolate helps enhance the production of 3 key neurotransmitters. This stimulated production is important because many antidepressants require a sufficient amount of neurotransmitters associated with mood.1-3,5,7

L-methylfolate helps enhance production of 3 key neurotransmitters. This stimulated production is important because many antidepressants require a sufficient amount of neurotransmitters associated with mood.

Copyright ©2008 Stephen M. Stahl. Reproduced with the permission of Cambridge University Press.5

Some patients have an impaired ability to fully metabolize folate

Age, medications, lifestyle, nutrition, and other health-related factors may affect folate or one-carbon metabolism8

A majority of patients with MDD may not be able to fully metabolize folate into its active form due to a methylenetetrahydrofolate reductase (MTHFR) polymorphism.

MTHFR polymorphisms are associated with a decrease in folate concentrations, which may lead to an increased risk of depressive symptoms. MTHFR polymorphisms also may compromise the ability to convert folic acid into the active form, L-methylfolate, that helps support monoamine regulation which helps to improve mood.9

 

Discover the DEPLIN® Difference

Discover the DEPLIN® Difference

See how DEPLIN® is different from supplemental folic acid.


BRAND DIRECT HEALTH

Savings, support, and resources
for patients taking DEPLIN®

Save on DEPLIN®
Help Patients Save on DEPLIN®

References: 1. Stahl SM. CNS Spectr. 2007;12(10):739-744. 2. Bottiglieri T. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(7):1103-1112. 3. Spector R, Lorenzo AV. Am J Physiol. 1975;229(3):777-782. 4. Papakostas GI, Shelton RC, Zajecka JM, et al. Am J Psychiatry. 2012;169(12):1267-1274. 5. Stahl SM. J Clin Psychiatry. 2008;69(9):1352-1353. 6. DEPLIN [package insert]. Shreveport, LA: Alfasigma USA, Inc. 2024. 7. Belmaker RH, Agam G. N Engl J Med. 2008;358(1):55-68. 8. Ginsberg LD, Oubre AY, Daoud YA. Innov Clin Neurosci. 2011;8(1):19-28. 9. Kelly CB, McDonnell AP, Johnston TG, et al. J Psychopharmacol. 2004;18(4):567-571. 10. Gilbody S, Lewis S, Lightfoot T. Am J Epidemiol. 2007;165(1):1-13.

DEPLIN® is a medical food for use only under medical supervision for the clinical dietary management of depression and schizophrenia and is specially formulated to meet the distinctive nutritional requirement for these condition.

Manufactured and Distributed by:
Alfasigma USA, Inc.
Shreveport, LA 71104
© 2024 Alfasigma USA, Inc.


ALFASIGMA